Prof Ho and his team used IDentif.AI and explored different combinations and the most precise dosing needed, to amplify the effects of both molnupiravir and Paxlovid against Omicron. — AZMAN GHANI/The Star
SINGAPORE: Researchers in Singapore are hoping artificial intelligence (AI) can help better fight Covid-19 infections, with AI determining the most optimal combination of antiviral drugs and the correct dosing.
A recent study led by Professor Dean Ho, director of the Institute for Digital Medicine at the NUS Yong Loo Lin School of Medicine, has shown some promise.
Already a subscriber? Log in.
Unlock 30% Savings on Ad-Free Access Now!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
